Richard Furie, MD

Richard Furie, MD, is Chief of the Division of Rheumatology at Northwell Health.

Articles by Richard Furie, MD

Insights: Obinutuzumab Faces Integration Challenges, Long-Term Potential in Lupus Nephritis

ByLuke Halpern, Associate Editor,Richard Furie, MD

March 11th 2025

Expert: Obinutuzumab Shows Promise in Lupus Nephritis, Reinforcing Role in High-Disease Patients

ByLuke Halpern, Associate Editor,Richard Furie, MD

March 4th 2025

Obinutuzumab is effective in reducing proteinuria and preserving kidney function in lupus nephritis, with consistent benefits across high-disease activity subgroups.

Richard Furie, MD

Articles by Richard Furie, MD

Insights: Obinutuzumab Faces Integration Challenges, Long-Term Potential in Lupus Nephritis

Expert: Obinutuzumab Shows Promise in Lupus Nephritis, Reinforcing Role in High-Disease Patients

Latest Updated Articles

Trending on Pharmacy Times

FDA Notifies Flu Vaccine Makers to Add Warning for Increased Febrile Seizure Risk in Young Children Day Following Vaccination

Oral Semaglutide Approved to Reduce the Risk of Cardiovascular Events

In 2026, Pharmacists Will Be Driving Change Across the Care Continuum

AI-Powered Digital Twins Offer a New Window Into Tumor Metabolism in Brain Cancer

FDA Finds No Increased Suicide Risk With GLP-1 Medications, Requests Removal of Warning Labels